Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.855
+0.115 (3.07%)
Aug 25, 2026, 10:01 AM EDT - Market open
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $960.62 million as of August 25, 2026. Its market cap has decreased by -34.76% in one year.
Market Cap
960.62M
Enterprise Value
961.30M
1-Year Change
-34.76%
Ranking
Category
Stock Price
$3.86
ChartMarket Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $960.62M, an increase of 295.80%. That is a compound annual growth rate of 11.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 960.62M | -32.18% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geron | 976.56M |
| Immix Biopharma | 973.65M |
| Annexon | 959.27M |
| Design Therapeutics | 953.12M |
| Cybin | 951.24M |
| Climb Bio | 941.95M |
| Aclaris Therapeutics | 928.83M |
| Olema Pharmaceuticals | 912.60M |